Human organoids: Fit for drug discovery?

Area of Science:

• Biotechnology
• Stem Cell Biology
• Pharmacology

Background:

• Organoids are 3D in vitro tissues from pluripotent stem cells (PSCs) mimicking human organs.
• They show promise for disease modeling, drug discovery, and toxicity testing.
• Current limitations include reliability and scalability for compound screening.

Purpose of the Study:

• To review current human PSC-derived organoid screening strategies.
• To highlight readouts, machine learning methods, and advantages over traditional models.
• To discuss challenges and future directions for organoid integration in drug development.

Main Methods:

• Literature review of organoid screening strategies.
• Analysis of available readouts and machine learning applications.
• Discussion of challenges such as assay robustness and throughput.

Main Results:

• Organoids provide physiologically relevant models for various applications.
• Machine learning can enhance organoid screening analysis.
• Significant challenges remain in standardization and scalability.

Conclusions:

• Organoid screening offers advantages but requires further validation.
• Standardized protocols and improved throughput are crucial for pharmaceutical integration.
• Advancing organoid technology will enhance drug candidate success rates.